People: MedCap publ AB (MEDCAP.ST)

MEDCAP.ST on Stockholm Stock Exchange

3.50SEK
12:00pm EDT
Price Change (% chg)

0.03kr (+0.86%)
Prev Close
3.47kr
Open
3.48kr
Day's High
3.50kr
Day's Low
3.41kr
Volume
34,350
Avg. Vol
88,741
52-wk High
4.49kr
52-wk Low
2.68kr

Search Stocks

Summary

Name Age Since Current Position

Bengt Julander

61 Chairman of the Board

Karl Tobieson

40 2011 Chief Executive Officer

Christer Ahlberg

42 Chief Executive Officer of Dunmedic AB

Lars-Ake Berglund

61 Chief Executive Officer of Abilia Group

Kenth-Olov Norman

54 2008 Chief Executive Officer of Unimedic AB

Krister Sjoberg

Chief Executive Officer of Quickels Systems AB

David Jern

41 2008 Investment Manager

Mats Thoren

42 2012 Investment Manager

Thomas Axelsson

55 2008 Director

Anders Hansen

39 2011 Director

Fredrik Mattsson

42 2012 Director

Kristina Patek

44 2008 Director

Biographies

Name Description

Bengt Julander

Mr. Bengt Julander serves as Chairman of the Board of Directors of MedCap publ AB. He has been Member of the Company's Board of Directors since 2007. He is Chief Executive Officer of Linc AB. He has been active within the life science sector since 1978. Mr. Julander serves as Member of the Boards of Anmedic AB, Eriksbergskliniken AB, Linc AB, LincInvest AB, nWise AB, Pharmalink AB, Stille AB, Vetgross AB, Abilia Sverige Holding AB and Unimedic AB. He is a pharmacist by profession.

Karl Tobieson

Mr. Karl Tobieson has served as Chief Executive Officer of MedCap publ AB since June 16, 2008. Previously, he was also President of Abilia within the Company from November 27, 2009 until January 10, 2011. Mr. Tobieson has experience as consultant within corporate finance. In the past, he worked for Centrecourt AB, Cell Innovation and Volvo. He is Chairman of the Boards of Abilia Sverige Holding AB, Quickels Systems AB and DUnmedic AB, as well as Member of the Board of Unimedic AB and at two companies related to Tobieson & Svennewall. He has been liquidator in GEWAB AB liquidation. Mr. Tobieson holds a Master of Science degree in Civil Engineering.

Christer Ahlberg

Mr. Christer Ahlberg serves as Chief Executive Officer of Dunmedic AB, a subsidiary of MedCap publ AB. He has been employed at the Company since 2010. He has experience from Sales and Marketing roles within the pharmaceutical industry. He previously worked for Astra, AstraZeneca, MEDA, Wyeth and Eisai AB. Mr. Ahlberg holds a degree in Economics and Business Administration with focus on Marketing.

Lars-Ake Berglund

Mr. Lars-Ake Berglund serves as Chief Executive Officer of Abilia Group within MedCap publ AB. Previously, he served as Chief Executive Officer of Handitek AB within the Company from 1997. He has been employed by the Company since 2009. Prior to this, he held different positions within Ericsson Radar between 1977 and 1990. He holds a Master of Science degree in Engineering.

Kenth-Olov Norman

Mr. Kenth-Olov Norman has served as Chief Executive Officer of Unimedic AB within MedCap publ AB since May 1, 2008. He is has been employed at the company since its foundation in 1992. Mr. Norman started in the pharmaceutical sector in 1979. He previously was Production Manager of Unimedic and Pharmacia's Matfors. He holds a Master of Science degree in Engineering.

Krister Sjoberg

Mr. Krister Sjoberg serves as Chief Executive Officer of Quickels Systems AB within MedCap publ AB. He has been employed by Quickels since 2010.

David Jern

Mr. David Jern has been Investment Manager at MedCap publ AB since 2008. He has over 15 years of experience in international business development within health care industry. He was Management Consultant in Arthur D. Little and Booz Allen, and Chief Executive Officer for a company within the industry. He is Member of the Board of Unimedic AB, Abilia Sverige holding AB and other companies within the industry. Since March 2013, he has been Chief Executive Officer of Toby Churchill Ltd, a subsidiary of Abilia Sverige Holding AB. He holds a Master of Engineering degree in Biotechnology and a Master of Science degree in Economics and Business Administration.

Mats Thoren

Mr. Mats Thoren has been Investment Manager at MedCap publ AB since autumn 2012. He has experience from medical technology sector, including from Handelsbanken Capital Markets as Account Manager for the heath sector, as Analyst within biotechnology and medical technology at Enskilda Securities and as Investment Manager at Catella Healthcare AB. He is Member of the Board of a number of companies within the industry.

Thomas Axelsson

Mr. Thomas Axelsson has served as Member of the Board of Directors of MedCap publ AB since 2008. He has been Chief Executive Officer of Vitrolife AB (publ) since October 2011. Previously, he served as President and Chief Executive Officer of Artema Medical AB and Stille AB, and as Business Area Manager with Baxter Medical AB, among others. He also has experience as Chairman of the Boards of Neoventa Medical AB, CMA Microdialysis AB, Airsonett AB, Quickcool AB and Cohr Group AB.

Anders Hansen

Mr. Anders Hansen has been Member of the Board of Directors of MedCap publ AB since 2011. He has been working in the life science industry since 2000. Previously, he served at Catella Healthcare, Dagens Industri, Boston Consulting Group and Sciencecap. He is Member of the Board of Executive Health Sweden. He is Psychiatrist and holds a Master of Science degree in Economics and Business Administration from Handelshogskolan i Stockholm.

Fredrik Mattsson

Mr. Fredrik Mattsson has been Member of the Board of Directors of MedCap publ AB since August 31, 2012. He has experience from many branches of life science and business development. He is Investment Manager at Bure Equity AB. He is Chairman of the Board of Xvivo perfusion AB and Member of the Boards of Directors of Dipylon Medical AB, Theducation AB, Vitrolife AB and Mercuri Inetrnational Group AB. He previously held positions in Gambro, Vittra Education and McKisney. He is Civil Engineer.

Kristina Patek

Ms. Kristina Patek has served as Member of the Board of Directors of MedCap publ AB since 2008. She has 15 years of experience from private equity. Previously, she worked for Ratos between 2001 and 2008, and before, she held Chief Executive Officer position at Cell Innovation between 1999 and 2001 and served at Accenture between 1994 and 1999. Ms. Patek is Member of the Boards of Directors of Brand Factory Group AB, Bookstop/Pocketstallet AB, Didner & Gerge Fonder AB, minomin Holding AB, Scope Capital Advisory AB and Vangsgaard AB. She holds a Master’s degree in Economics.

Basic Compensation

Search Stocks